The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...

Neoadjuvant chemotherapy for advanced ovarian cancer was initially administered as an alternative treatment for patients not suitable for primary debulking surgery (PDS) because of unresectable ...

在她的坚持下，这篇论文最终在Vaccines期刊发表，论文题为：An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer ...

Dongan Hills resident Melissa Hickey turned her chemotherapy sessions into carnivals, movie sets and tea parties.

Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...

Nurse navigators and APPs are key members of the multidisciplinary team who can lead and implement QI efforts to ensure ...

("CSPC") (stock code: 1093.HK) jointly announced that an application for a phase III clinical study (Study ID: KN026-004) of the anti-HER2 bispecific antibody KN026 combined with albumin-bound ...

Perioperative chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) shows promising long-term benefits with ...